Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Market Closed - Nasdaq
Other stock markets
 21:00:00 27/06/2024 BST 		5-day change 1st Jan Change
3.69 USD -0.27% Intraday chart for Prelude Therapeutics Incorporated -0.40% -13.58%
06-20 Barclays Downgrades Prelude Therapeutics to Underweight From Equalweight With $3 Price Target MT
06-12 Transcript : Prelude Therapeutics Incorporated Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 10:40 AM

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
GL
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
GL
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GL
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
GL
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
GL
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
GL
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
GL
Prelude Therapeutics Announces $25 Million Private Placement
GL
Prelude Therapeutics Incorporated : Announces $25 Million Private Placement - Form 8-K
PU
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
GL
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
GL
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
AQ
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference 
AQ
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference 
GL
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
GL
Prelude Therapeutics Incorporated : August 2023 Corporate Deck
PU
Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
AQ
Prelude Therapeutics To Participate in Jefferies Healthcare Conference
AQ
PRELUDE THERAPEUTICS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Prelude Therapeutics Announces Pricing of Public Offering
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. News Prelude Therapeutics Incorporated
  5. Press Releases